Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention
Published: November 30, 2020
![Ethnic woman in medical consultation with female doctor](/-/media/PHD-Images/Science-News/e/t/ethnic_woman_in_medical_consultation_with_female_doctor.jpg?h=343&iar=0&mh=515&mw=515&w=515)
- This scientific statement is intended to raise awareness of the significant adverse cardio-metabolic health-related changes accompanying midlife and the menopause transition (MT).
- New findings on menopause and cardiovascular disease (CVD) risk have emerged since the AHA published Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women 2011 Update; the new information should be considered.
- This statement expands on the 2011 guideline by providing updated, detailed information specific to MT and CVD in women.
Supporting Materials
- Commentary: Menopause Transition and Cardiovascular Health: Time Matters by Licy L. Yanes Cardozo, MD and Damian G. Romero, PhD, FAHA
- Top Things to Know: Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention
- AHA News: Report on latest menopause science looks at heart risks
- News Release: Heart disease risk in women increases leading up to menopause; early intervention is key